Clinical Trials Directory

Trials / Terminated

TerminatedNCT02569749

Sleep Apnea Screening

Sleep Apnea-Hypopnea Syndrome Screening

Status
Terminated
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Arrhythmia Network Technology S.L. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRTD), 3) heart failure and preserved left ventricular ejection fraction (LVEF) and 4) heart failure and reduced LVEF.

Conditions

Interventions

TypeNameDescription
OTHERBerlin and Epworth questionaries
OTHERSleep apnea monitoring in those patients in whom a pacemaker with monitoring apnea system has been implanted.
OTHERNight polygraph / Polysomnography

Timeline

Start date
2015-06-01
Primary completion
2016-03-01
First posted
2015-10-07
Last updated
2015-11-03

Locations

9 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02569749. Inclusion in this directory is not an endorsement.

Sleep Apnea Screening (NCT02569749) · Clinical Trials Directory